Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
NCT06654895
Infections, Inflammation
Gainesville, Florida, United States
View Trial DetailsNCT Number: NCT07425587
The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.
Interested in participating?
Request Info22 year and older
All sexes
Observational
University of Florida College of Medicine, Gainesville, Florida, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 3 days after inclusion
Time frame: Within 30 days after inclusion
Time frame: Within 7 days after inclusion
Time frame: Within 3 days after inclusion
SOFA score has a range of 1 to 24, where higher scores represent higher degrees of single or multiple organ failure(s)
Time frame: Participants will be followed up for hospital length of stay for up to 30 days
Time frame: Within 30 days after inclusion
Time frame: Within 30 days after inclusion
As assessed by cultures and/or viral testing.
Time frame: Within 30 days after inclusion
Participants will be followed up for progression to septic shock for up to 30 days
Time frame: Within 30 days after inclusion
Participants will be followed up for 30 days for all-cause mortality
Time frame: within 30 days after inclusion
Time frame: Within 30 days after inclusion
Time frame: Within 30 days after inclusion
Time frame: Within 30 days after inclusion
Time frame: Within 30 days after inclusion
Time frame: Within 30 days after inclusion
Time frame: Within 30 days after inclusion
Contact information is provided by the study sponsor or research team.
Bluejay Diagnostics, Inc.
Industry
Acronym: SYMON III
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06654895
Infections, Inflammation
Gainesville, Florida, United States
View Trial DetailsNCT06809868
Coinfection, Infections
San Francisco, California, United States
View Trial DetailsNCT03677102
Infections, Inflammation
Calgary, Alberta, Canada
View Trial DetailsNCT04130230
Infections, Inflammation
Tanta, EL-Gharbia, Egypt
View Trial Details